Feedback / Questions
censavudine (TPN-101) - Transposon Therap, Yale University
https://www.prnewswire.com/news-releases/transposon-announces-tpn-101-selected-for-inclusion-in-the-phase-23-healey-als-platform-trial-building-on-the-success-of-phase-2-study-in-c9orf72-related-als-302466319.html
May 28, 2025
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Next